Abstract
Genetically modifying myeloid cells to produce IL12 can overcome immune suppression. These cells boost immune cell numbers in the lungs of mice with metastasizing tumors and reverse gene expression patterns associated with immunosuppression. The cells can also extend survival in mice that have had surgery to remove a primary tumor.
©2021 American Association for Cancer Research.
2021
American Association for Cancer Research.
You do not currently have access to this content.